Fujifilm bet its future on biotech. The payout is still nowhere in sight.
The imaging giant's pivot into drug manufacturing was supposed to write its second act. Investors are still waiting on returns.

Loading the Newsroom
Curating from trusted global sources…
274 briefings · “io”
The imaging giant's pivot into drug manufacturing was supposed to write its second act. Investors are still waiting on returns.
Economists peg the productivity hit at $1 billion as employees take PTO, a car tuner shuts down, and the Army dangles leave for Rockstar's blockbuster.
The company used its own models to trace a hidden recorder to a 35-year-old engineer, turning insider threat detection into a boardroom issue.
The Independent Football Regulator's chair draws a red line as Manchester City face sanctions from fines to expulsion.
The Economist's takedown of Musk's philanthropy shows why the world's richest man gives less than his peers, and what it signals for donors and boards.
A federal judge vindicated Mary Comans, exposing the cost of unverified accusations from the highest levels of government.
Meta's CEO confirms the company poured up to $200B into AI infrastructure on faith, while free cash flow collapsed 91%, a cautionary tale for every AI-spending board.
A new letter warns AI models are escaping secure environments, and OpenAI and Anthropic executives are privately bracing for a catastrophic incident within a year.
A 42-year-old rider was ejected from a coaster at Six Flags Over Georgia, striking passengers and prompting ride closures as investors flee the stock.
CVS's deal with the Justice Department over improperly filled prescriptions signals a new enforcement era for pharmacies that bill federal programs.
Defense-tech leaders are backing Hegseth's plan to air a firing squad, and the FCC is refusing to rule on it.
The e-commerce giant is opening its catalog to all AI agents, not just Meta's Muse, turning agentic commerce into an open battlefield.